Berkhout B

Publications:

Search this table:

Title	Authors	Year	Journal
Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan.	Berkhout B	2006	J Infect Dis
Human parechovirus infections in Dutch children and the association between serotype and disease severity.	Berkhout B	2006	Clin Infect Dis
Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.	Berkhout B	2005	J Virol
The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation.	Berkhout B	2005	Biochemistry
Evidence of genetic variability of human immunodeficiency virus type 1 in plasma and cervicovaginal lavage in ethiopian women seeking care for sexually transmitted infections.	Berkhout B	2005	AIDS Res Hum Retroviruses
Suppression of RNA interference by adenovirus virus-associated RNA.	Berkhout B	2005	J Virol
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.	Berkhout B	2005	Nucleic acids research
Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.	Berkhout B	2005	J Clin Invest
A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.	Berkhout B	2005	J RNAi Gene Silencing
Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity.	Berkhout B	2005	J Virol
It's the virus, stupid--part 2.	Berkhout B	2005	Retrovirology
RNAi Europe 2005.	Berkhout B	2005	IDrugs
Aggressive HIV-1?	Berkhout B	2005	Retrovirology
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.	Berkhout B	2005	J Virol
Protein promiscuity: drug resistance and native functions--HIV-1 case.	Berkhout B	2005	J Biomol Struct Dyn
Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.	Berkhout B	2005	J Acquir Immune Defic Syndr
Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.	Berkhout B	2005	J Virol
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.	Berkhout B	2005	Proceedings of the National Academy of Sciences of the United States of America
Construction of a minimal HIV-1 variant that selectively replicates in leukemic derived T-cell lines: towards a new virotherapy approach.	Berkhout B	2005	Cancer research
High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.	Berkhout B	2005	Scand J Infect Dis
Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter.	Berkhout B	2005	Nucleic acids research
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium.	Berkhout B	2005	BMC Infect Dis
Retroviral superinfection resistance.	Berkhout B	2005	Retrovirology
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase.	Berkhout B	1997	J Virol
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.	Berkhout B	1996	The EMBO journal

Showing 1 to 25 of 25 entries

Berkhout B

Publications:

Author page

Help icons:

Using Polbase tables: